UK Trial Could Help Pick Best Covid Vaccine Boosters
Initial Results Due In September
Results will be important in fight against new variants, for second-generation vaccines and AstraZeneca’s controversy-hit jab.
You may also be interested in...
Arriving two to three months later than planned, Novavax’s nanoparticle-based vaccine is still a welcome addition to the field, for both rich and poor countries.
Key investors have pledged more patience in CEO Walmsley’s turnaround but they will be expecting a convincing vision of the future, more dynamic, GSK.
Aiming to mimic public-private COVID-19 vaccine success, the US NIH will fund pandemic drug research, including taking candidates up to Phase II.